Royal Bank of Canada
BME icon

Royal Bank of Canada’s BlackRock Health Sciences Trust BME Stock Holding History

Royal Bank of Canada’s Portfolio BME Stock Details BME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.19M Buy
160,682
+218
+0.1% +$8.99K ﹤0.01% 2252
2025
Q4 		$6.6M Buy
160,464
+18,442
+13% +$728K ﹤0.01% 2224
2025
Q3 		$5.29M Buy
142,022
+818
+0.6% +$29.7K ﹤0.01% 2628
2025
Q2 		$5.15M Sell
141,204
-2,342
-2% -$84.9K ﹤0.01% 2550
2025
Q1 		$5.55M Buy
143,546
+684
+0.5% +$27.1K ﹤0.01% 2176
2024
Q4 		$5.42M Sell
142,862
-6,440
-4% -$257K ﹤0.01% 2252
2024
Q3 		$6.26M Buy
149,302
+16,013
+12% +$665K ﹤0.01% 2105
2024
Q2 		$5.45M Sell
133,289
-4,049
-3% -$161K ﹤0.01% 2115
2024
Q1 		$5.69M Buy
137,338
+11,923
+10% +$499K ﹤0.01% 2074
2023
Q4 		$5.07M Buy
125,415
+14,646
+13% +$559K ﹤0.01% 2220
2023
Q3 		$4.34M Buy
110,769
+12,862
+13% +$512K ﹤0.01% 2205
2023
Q2 		$3.98M Buy
97,907
+2,110
+2% +$86.8K ﹤0.01% 2275
2023
Q1 		$4.01M Buy
95,797
+852
+0.9% +$35.8K ﹤0.01% 2250
2022
Q4 		$4.14M Buy
94,945
+1,938
+2% +$82.4K ﹤0.01% 2291
2022
Q3 		$3.61M Buy
93,007
+6,059
+7% +$258K ﹤0.01% 2341
2022
Q2 		$3.69M Buy
86,948
+1,968
+2% +$85.5K ﹤0.01% 2352
2022
Q1 		$3.87M Sell
84,980
-2,026
-2% -$89.8K ﹤0.01% 2469
2021
Q4 		$4.22M Sell
87,006
-1,960
-2% -$92.8K ﹤0.01% 2514
2021
Q3 		$4.24M Sell
88,966
-36,894
-29% -$1.8M ﹤0.01% 2428
2021
Q2 		$6.1M Buy
125,860
+2,143
+2% +$102K ﹤0.01% 2186
2021
Q1 		$5.72M Buy
123,717
+4
+0% +$190 ﹤0.01% 2138
2020
Q4 		$5.89M Buy
123,713
+746
+0.6% +$33.8K ﹤0.01% 2081
2020
Q3 		$5.27M Sell
122,967
-12,919
-10% -$553K ﹤0.01% 1969
2020
Q2 		$5.54M Buy
135,886
+2,312
+2% +$93.3K ﹤0.01% 1874
2020
Q1 		$4.82M Buy
133,574
+57,937
+77% +$2.31M ﹤0.01% 1830
2019
Q4 		$3.21M Buy
75,637
+2,194
+3% +$87K ﹤0.01% 2471
2019
Q3 		$2.81M Buy
73,443
+2,440
+3% +$93.9K ﹤0.01% 2486
2019
Q2 		$2.76M Sell
71,003
-1,506
-2% -$57.2K ﹤0.01% 2517
2019
Q1 		$2.88M Sell
72,509
-117
-0.2% -$4.63K ﹤0.01% 2417
2018
Q4 		$2.65M Sell
72,626
-1,633
-2% -$64.2K ﹤0.01% 2443
2018
Q3 		$3.16M Buy
74,259
+7,416
+11% +$301K ﹤0.01% 2494
2018
Q2 		$2.58M Buy
66,843
+2,746
+4% +$99.5K ﹤0.01% 2535
2018
Q1 		$2.24M Buy
64,097
+3,991
+7% +$142K ﹤0.01% 2603
2017
Q4 		$2.19M Buy
60,106
+6,243
+12% +$226K ﹤0.01% 2653
2017
Q3 		$1.96M Buy
53,863
+3,955
+8% +$144K ﹤0.01% 2676
2017
Q2 		$1.83M Buy
49,908
+7,610
+18% +$267K ﹤0.01% 2659
2017
Q1 		$1.46M Sell
42,298
-1,507
-3% -$50.7K ﹤0.01% 2787
2016
Q4 		$1.39M Buy
43,805
+2,105
+5% +$70.5K ﹤0.01% 2867
2016
Q3 		$1.42M Buy
41,700
+1,017
+2% +$35.9K ﹤0.01% 2816
2016
Q2 		$1.45M Sell
40,683
-18,205
-31% -$666K ﹤0.01% 2800
2016
Q1 		$2.09M Sell
58,888
-25,352
-30% -$895K ﹤0.01% 2423
2015
Q4 		$3.31M Sell
84,240
-134
-0.2% -$5.46K ﹤0.01% 2151
2015
Q3 		$3.17M Buy
84,374
+390
+0.5% +$17.2K ﹤0.01% 1881
2015
Q2 		$3.6M Buy
83,984
+3,535
+4% +$152K ﹤0.01% 1835
2015
Q1 		$3.46M Sell
80,449
-2,294
-3% -$95.7K ﹤0.01% 1847
2014
Q4 		$3.53M Buy
82,743
+5,072
+7% +$209K ﹤0.01% 1882
2014
Q3 		$2.98M Buy
77,671
+2,460
+3% +$90.5K ﹤0.01% 1999
2014
Q2 		$2.76M Buy
75,211
+5,966
+9% +$216K ﹤0.01% 2055
2014
Q1 		$2.56M Sell
69,245
-4,133
-6% -$152K ﹤0.01% 2065
2013
Q4 		$2.6M Buy
73,378
+1,332
+2% +$44.8K ﹤0.01% 2095
2013
Q3 		$2.35M Buy
72,046
+1,513
+2% +$50.2K ﹤0.01% 2094
2013
Q2 		$2.19M Buy
+70,533
New +$2.2M ﹤0.01% 1993

Other funds holding BME

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
NRW
Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Royal Bank of Canada's BME Position: Q1 2026 in Review

Royal Bank of Canada increased its BlackRock Health Sciences Trust (BME) stake by 0.14% in Q1 2026, buying an estimated $8.99K and bringing the position to 160,682 shares worth $6.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2252.

Royal Bank of Canada first reported a position in BME in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.6M in Q4 2025. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • Royal Bank of Canada held 160,682 shares of BlackRock Health Sciences Trust worth $6.19M as of Q1 2026.
  • Royal Bank of Canada bought 218 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $8.99K.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #2252 holding.
  • Royal Bank of Canada first reported a position in BlackRock Health Sciences Trust in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's BlackRock Health Sciences Trust position peaked at $6.6M in Q4 2025.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.